A systematic review of lung-sparing extirpative surgery for pleural mesothelioma

Journal of the Royal Society of Medicine

Volumn 104, Issue 2, 2011, Pages 69-80

  Teh, Elaine ^a   Fiorentino, Francesca ^b   Tan, Carol ^c   Treasure, Tom ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

CANCER STAGING; FOLLOW UP; HUMAN; LUNG RESECTION; PLEURA MESOTHELIOMA; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; SYSTEMATIC REVIEW;

EID: 79551607998     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2010.100345     Document Type: Review

References (40)

1. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345:535-9
2. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72
3. Rake C, Gilham C, Hatch J, Danton J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case control study. Br J Cancer 2009;100:1175-83
4. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63
5. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6
6. Martin-Ucar AE, Nakas A, Edwards JG,Waller DA. Casecontrol study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007;31:765-70 (Pubitemid 46528743)
7. Nakas A, Martin Ucar AE, Edwards JG,Waller DA. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008;33:83-8 (Pubitemid 350284603)
8. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 2008;34:886-91
9. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479-95
10. Ettinger DS. Malignant Pleural Mesothelioma. Fort Washington, PA: National Comprehensive Cancer Network; 2010. See www.nccn.org.
11. Schipper PH, Nichols FC, Thomse KM, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 2008;85:257-64
12. Lucchi M, Chella A, Melfi F, et al. Four-modality therapy in malignant pleural mesothelioma: a phase II study. J Thorac Oncol 2007;2:237-42 (Pubitemid 47181329)
13. Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 2008;7:102-6
14. Clarke CP, Knight SR, Daniel FJ, Seevanayagam S. Management of malignant mesothelioma by decortication and adjunct phototherapy. Asian Cardiovasc.Thorac Ann 2006;14:206-9
15. Colaut F, Toniolo L, Vicario G, et al. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma. Chir Ital 2004;56:781-6
16. Matzi V, Maier A,Woltsche M, Smolle-Juttner FM. Polyhematoporphyrin- mediated photodynamic therapy and decortication in palliation of malignant pleural mesothelioma: a clinical pilot study. Interact Cardiovasc Thorac Surg 2004;3:52-6 (Pubitemid 38481794)
17. de Vries WJ, Long MA. Treatment of mesothelioma in Bloemfontein, South Africa. Eur J Cardiothorac Surg 2003;24:434-40
18. Monneuse O, Beaujard AC, Guibert B, et al. Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies. Br J Cancer 2003;88:1839-43
19. Phillips PG, Asimakopoulos G, Maiwand MO. Malignant pleural mesothelioma: outcome of limited surgical management. Interact Cardiovasc Thorac Surg 2003;2:30-4
20. Yom SS, Busch TM, Friedberg JS, et al. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol 2003;78:75-81
21. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002;22:298-305 (Pubitemid 34831874)
22. Lee TT, Everett DL, Shu HK, et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2002;124:1183-9
23. Ceresoli GL, Locati LD, Ferreri AJ, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001;34:279-87
24. Colleoni M, Sartori F, Calabro F, et al. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori 1996;82:53-6
25. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience. J Surg Oncol 1995;60:262-7 (Pubitemid 26004391)
26. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995;60:100-5
27. Allen KB, Faber LP,Warren WH. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 1994;4:113-26
28. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Aust 1991;154:455-7, 460
29. Branscheid D, Krysa S, Bauer E, Bulzebruck H, Schirren J. Diagnostic and therapeutic strategy in malignant pleural mesothelioma. Eur J Cardiothorac Surg 1991;5:466-72
30. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13:4-9
31. Harvey JC, Fleischman EH, Kagan AR, Streeter OE. Malignant pleural mesothelioma: a survival study. J Surg Oncol 1990;45:40-2
32. Achatzy R, Beba W, Ritschler R, et al. The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 1989;3:445-7
33. Law MR, Gregor A, Hodson ME, Bloom HJ, Turner-Warwick M. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 1984;39:255-9
34. Treasure T, Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133:1414-18
35. Grossebner MW, Arifi AA, Goddard M, Ritchie AJ. Mesothelioma-VATS biopsy and lung mobilization improves diagnosis and palliation. Eur J Cardiothorac Surg 1999;16:619-23
36. Rintoul R,Winter R MESOVATS. London: UK Clinical Research Network; 2010. See http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=1352
37. Pass HI, Temeck BK, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997;4:628-33
38. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007;2:957-65
39. Utley M, Fiorentino F, Treasure T. Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg 2010;38:241-4
40. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988;6:527-35 (Pubitemid 18090702)